Speakers: Maya Hrachova, DO

Speaker Disclosures: Statements, opinions and results of studies contained in the program are those of the presenters and authors and do not reflect the policy or position of the Board of Regents of the University of Oklahoma (“OU”) nor does OU provide any warranty as to their accuracy or reliability.

Professional Practice Gap: Practitioners may not be aware of recent advances in Glioblastoma management.

Learning Objectives:

Upon completion of this session, participants will improve their competence and performance by being able to:

1. Review projected cancer statistics for 2023.

2. Review standard of care guidelines for Glioblastoma.

3. Discuss recent positive clinical trials, including DcVax-L and SurVaxM.